{"name":"Univar BV","slug":"univar-bv","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"trientine dihydrochloride","genericName":"trientine dihydrochloride","slug":"trientine-dihydrochloride","indication":"Wilson's disease (hepatic and neurological manifestations)","status":"marketed"}]}],"pipeline":[{"name":"trientine dihydrochloride","genericName":"trientine dihydrochloride","slug":"trientine-dihydrochloride","phase":"marketed","mechanism":"Trientine is a copper chelator that binds and removes excess copper from the body, reducing copper-mediated tissue damage.","indications":["Wilson's disease (hepatic and neurological manifestations)","Copper toxicity"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPQl9Mb0ZoX3ZsOTZaS0ZaNWNDam8tbk9tanZHbnJDSUMzR0Raa2dRUnNrZW5LT3NXSDhBeWRwTUt6d09lM3pNZ1I4X2VMeWh1Nm1QZ0VRMm43TXRFX3FSU3p6ejhhV0dCa1FpN043ZmxNNjdwZEw2anFxWFNkMnRfUEtyVmdHS0dsSnJweXBoRzg2LUxNeU1TNmVBX3pGczNnVVlDZHdheENURWdoWTluSi1rSFR2N1gyMGNyY2pHbnJ3V013UHJTUE1WVjlPdw?oc=5","date":"2026-02-25","type":"pipeline","source":"PharmTech.com","summary":"Univar Solutions Selected as Exclusive US and Canada Distributor for Ingredion Pharmaceutical Starches - PharmTech.com","headline":"Univar Solutions Selected as Exclusive US and Canada Distributor for Ingredion Pharmaceutical Starches","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPZUNKZ0d6d1JkOUJDTlF2ZEJuUGEwQXNYRFpRdmtZOGJwUE13cE9RRHhnZDBiQTQyYjBYVkJZN0R5UXRWaVVxRGJWajhWa2NGQzFDVUlBZEF1bHA5ZHVfTWNoNHB3eXR2ckQ1M2dDcnNWY3Rqd1hhUmctZ1QwTk1qeFMzRWJhVFlyV3pQZkx5THpuU2hvNEJuQ2dkb1gzYXV0X0NtUkJmdnA3QllCWjZLV0EzeFZObFRQaUVDTE1BaHNDeGNnOXltYXhJalMzREFXZGtOYUZEWTE1WklmTU5NbC0tS09RUQ?oc=5","date":"2026-02-24","type":"pipeline","source":"prnewswire.com","summary":"Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada - prnewswire.com","headline":"Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxNb08wdjVpX1ZHQ1ZsUS13Tnl5NllLZXBrc2gtSE9yVGpFYkFucnRzMjdsSnhSTkYwQ1dHQi05TERWbExfZ2dFdnNLQ3h4elMzcnJHYWxyVXJLNG9TZkFreTFabWEyUnZWQlBHNEw4QW54RDdkaEFOSTQyU3VseC1xb1I5RWZaUFlwcDRlZnBNLVZrVHBZTExqQ25sUWdPRDhwZnJ1YXh2VVVSaHdlS3lINktKM0xNQnBUVUdwRmhnaE01TDVkMXNaOWxYekxacmNSYWNqNTFxYWdpZHhSUFgyUHhoeGRjeEJXZ1FxS0g4S3F2eDNVSFJGalJ2bFB0ZktnSmRPUUVGX1U?oc=5","date":"2026-01-27","type":"deal","source":"prnewswire.com","summary":"Univar Solutions and Ashland Forge Exclusive Partnership for Cellulose Ethers in Food and Beverage Sector Throughout EMEA - prnewswire.com","headline":"Univar Solutions and Ashland Forge Exclusive Partnership for Cellulose Ethers in Food and Beverage Sector Throughout EME","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxObFgxSDMtTjE2bDZLZGdUVllWanNIRFpHTVZ1VjM2ajJTSlBfYUlRZlF3b3YtbjV1MWNUMFJKZTlqWHNPbmE2WmdYc1NfSkNmbVV4eGxZT2N0VVM3NFlMWEw1Wk9rbGdyUzBOTC1KdVR5eExSWTFXYThpbDFIMUtPTWFhVFN5aUZZd2hBeHR3MDBhVkJLMHI0YktXUGhQRjZRWHl4cTFWVXJ4QzlQQkllWElRVGZTREhmMHlTYjBxLXBRYkxXUklydk8wWUEtUzM1Uml1bGxPOWpfT28?oc=5","date":"2024-04-01","type":"pipeline","source":"prnewswire.com","summary":"Koel USA Inc. Selects Univar Solutions to Represent Specialty Pigment and Dyes Portfolio - prnewswire.com","headline":"Koel USA Inc. Selects Univar Solutions to Represent Specialty Pigment and Dyes Portfolio","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}